This article is a correction to:
Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
Xiaoying Li
Jing Wen
Hongtao LiA Corrigendum on
Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: a case report
by Li X, Wen J, Li H, Huang Y and Zhou H (2023). Front. Oncol. 13:1114397. doi: 10.3389/fonc.2023.1114397
In the published article, there was an error in Figure 3G as published. We used the wrong image in Figure 3G which is duplicated with Figure 3F. The corrected Figure 3 and its caption “Immunohistochemical results (400×). (A) Hematoxylin and eosin-stained section result; (B) CD56 staining specific for neuroendocrine differentiation; (C) CK-L staining specific for neuroendocrine differentiation; (D) CK-pan staining specific for neuroendocrine differentiation; (E) GATA-3 staining specific for neuroendocrine differentiation; (F) Ki-67 staining specific for neuroendocrine differentiation; (G) Syn staining specific for neuroendocrine differentiation” appear below.
Figure 3
Figure 3 Immunohistochemical results (400×). (A) Hematoxylin and eosin-stained section result; (B) CD56 staining specific for neuroendocrine differentiation; (C) CK-L staining specific for neuroendocrine differentiation; (D) CK-pan staining specific for neuroendocrine differentiation; (E) GATA-3 staining specific for neuroendocrine differentiation; (F) Ki-67 staining specific for neuroendocrine differentiation; (G) Syn staining specific for neuroendocrine differentiation.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cardiac infarction, PD-1 inhibitor treatment, small cell neuroendocrine carcinoma the ureter, case report, literature review
Citation: Li X, Wen J, Li H, Huang Y and Zhou H (2024) Corrigendum: Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: a case report. Front. Oncol. 14:1438794. doi: 10.3389/fonc.2024.1438794
Received: 12 June 2024; Accepted: 22 June 2024;
Published: 05 July 2024.
Edited and Reviewed by:
Salvatore Siracusano, University of L’Aquila, ItalyCopyright © 2024 Li, Wen, Li, Huang and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaoying Li, bHh5bHh5MTMxNDFAMTYzLmNvbQ==